Clicky

Pfizer Inc(PFIZ34)

Description: Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.


Keywords: Biotechnology Life Sciences Disease Pharmacy Vaccines Contract Manufacturing Immunotherapies Hemophilia Biosimilar Biopharmaceutical Products Amyloidosis Eliquis Endocrine Diseases Retacrit Etanercept Pneumococcal Disease Tick Borne Encephalitis Xeljanz Bene Fix Chronic Immune And Inflammatory Diseases Enbrel Genotropin Inflectra Inlyta Medrol Meningococcal Disease Nimenrix Premarin Prevnar Sutent Vfend Vyndaqel Xtandi Zithromax

Home Page: www.pfizer.com

235 East 42nd Street
New York, NY 10017
United States
Phone: 212 733 2323


Officers

Name Title
Dr. Albert Bourla D.V.M., DVM, Ph.D. Chairman & CEO
Mr. Frank A. D'Amelio CFO & Exec. VP
Dr. Mikael Dolsten M.D., Ph.D. Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical
Mr. Douglas M. Lankler Exec. VP & Gen. Counsel
Mr. John D. Young Advisor
Ms. Angela Hwang Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.
Mr. David M. Denton Chief Financial Officer & Exec. VP
Ms. Jennifer B. Damico Sr. VP, Controller & Principal Accounting Officer
Ms. Lidia L. Fonseca Exec. VP and Chief Digital & Technology Officer
Mr. Christopher J. Stevo CFA Sr. VP & Chief Investor Relations Officer

Exchange: SA

Country: BR

Currency: Brazilian real (R$)

Forward PE: 10.9409
Trailing PE: 9.0386
Price-to-Book MRQ: 3.2951
Price-to-Sales TTM: 15.4289
IPO Date:
Fiscal Year End: December
Full Time Employees: 79000
Back to stocks